Coupang is facing filings with the SEC regarding stock stake increases, alongside analyst rating changes affecting its stock price.
2 reports, 1 independent
Updated Jul 25
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Coupang is facing filings with the SEC regarding stock stake increases, alongside analyst rating changes affecting its stock price.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Analyst ratings disclosed via SEC filing involving Morgan Stanley, Royal Bank of Canada, and the SEC.
- Altria disclosed trading activity via required filings with the SEC, coinciding with analyst rating changes and price targets.
- Moderna stock activity, including institutional purchases and analyst ratings, was disclosed to the SEC.
- A company filed disclosures with the SEC, and a bank subsequently issued rating and price targets.
- Analyst rating targets are affecting stock prices, and required reports regarding ownership stakes are being filed with the SEC for Bank of America and KBR, Inc.
Coverage
Newest first; wire copies grouped- tickerreport.comSei Investments Co. Raises Stake in Coupang, Inc. $CPNG